http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111759840-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4422 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4164 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1617 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4422 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4164 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16 |
| filingDate | 2020-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-111759840-B |
| titleOfInvention | Pharmaceutical composition for preventing and treating myocardial ischemia and preparation method and application thereof |
| abstract | The invention discloses an application of secnidazole in preparing a medicament for treating and/or preventing myocardial ischemia. The invention also discloses a pharmaceutical composition for treating and/or preventing myocardial ischemia, which comprises secnidazole and pharmaceutically acceptable excipient. Pharmacodynamic experiment results show that secnidazole has a protective effect on experimental myocardial ischemic injury, can obviously reduce myocardial infarction area, relieve myocardial damage degree, reduce serum MDA content, increase SOD active enzyme content, can effectively resist acute myocardial ischemia, protects myocardium, and thus improves symptoms of myocardial ischemia. |
| priorityDate | 2020-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 112.